DK0984960T3 - N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister - Google Patents

N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister

Info

Publication number
DK0984960T3
DK0984960T3 DK98924383T DK98924383T DK0984960T3 DK 0984960 T3 DK0984960 T3 DK 0984960T3 DK 98924383 T DK98924383 T DK 98924383T DK 98924383 T DK98924383 T DK 98924383T DK 0984960 T3 DK0984960 T3 DK 0984960T3
Authority
DK
Denmark
Prior art keywords
cck
triazole
agonists
indole carboxamides
carboxamides
Prior art date
Application number
DK98924383T
Other languages
Danish (da)
English (en)
Inventor
Eric Bignon
Jean-Pierre Bras
Cointet Paul De
Pierre Despeyroux
Daniel Frehel
Danielle Gully
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0984960T3 publication Critical patent/DK0984960T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK98924383T 1997-05-13 1998-05-06 N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister DK0984960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1998/000905 WO1998051686A1 (fr) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a

Publications (1)

Publication Number Publication Date
DK0984960T3 true DK0984960T3 (da) 2003-05-26

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924383T DK0984960T3 (da) 1997-05-13 1998-05-06 N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister

Country Status (35)

Country Link
EP (1) EP0984960B1 (de)
JP (1) JP2001524980A (de)
KR (1) KR20010012541A (de)
CN (1) CN1263528A (de)
AR (1) AR011729A1 (de)
AT (1) ATE232207T1 (de)
AU (1) AU725530B2 (de)
BR (1) BR9811465A (de)
CA (1) CA2289573A1 (de)
CO (1) CO4940485A1 (de)
CZ (1) CZ289484B6 (de)
DE (1) DE69811223T2 (de)
DK (1) DK0984960T3 (de)
DZ (1) DZ2486A1 (de)
EE (1) EE9900524A (de)
ES (1) ES2190081T3 (de)
FR (1) FR2763337B1 (de)
GT (1) GT199800068A (de)
HR (1) HRP980258B1 (de)
HU (1) HUP0002763A3 (de)
ID (1) ID22911A (de)
IL (1) IL132903A0 (de)
IS (1) IS5235A (de)
NO (1) NO995513L (de)
NZ (1) NZ500637A (de)
PL (1) PL336772A1 (de)
RU (1) RU2175323C2 (de)
SI (1) SI0984960T1 (de)
SK (1) SK154299A3 (de)
TR (1) TR199902795T2 (de)
TW (1) TW396155B (de)
UY (1) UY24997A1 (de)
WO (1) WO1998051686A1 (de)
YU (1) YU57999A (de)
ZA (1) ZA983997B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
AU2002226330A1 (en) * 2000-10-26 2002-05-06 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (de) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indol-2-carbonsäureamide als Faktor-Xa-Hemmer
EP1479677A1 (de) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Neue Indolderivate als Faktor Xa-Inhibitoren
EP1532980A1 (de) * 2003-11-24 2005-05-25 Novo Nordisk A/S N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
ATE528006T1 (de) * 2007-01-26 2011-10-15 Merck Sharp & Dohme Substituierte aminopyrimidine als cholecystokinin-1-rezeptormodulatoren
WO2010007046A2 (en) * 2008-07-15 2010-01-21 Novartis Ag Organic compounds
US8580831B2 (en) * 2009-06-09 2013-11-12 Actelion Pharmaceuticals Ltd. Fluorinated aminotriazole derivatives
EP2490659B1 (de) * 2009-10-22 2017-03-01 Henkel AG & Co. KGaA Mittel zur temporären verformung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein chitosan
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
MX2022004142A (es) 2019-10-07 2022-09-21 Kallyope Inc Agonistas de gpr119.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
IL132903A0 (en) 2001-03-19
AR011729A1 (es) 2000-08-30
TW396155B (en) 2000-07-01
ID22911A (id) 1999-12-16
FR2763337A1 (fr) 1998-11-20
CN1263528A (zh) 2000-08-16
NO995513D0 (no) 1999-11-11
SI0984960T1 (en) 2003-06-30
FR2763337B1 (fr) 1999-08-20
UY24997A1 (es) 2000-10-31
EP0984960B1 (de) 2003-02-05
YU57999A (sh) 2002-06-19
DZ2486A1 (fr) 2003-02-01
IS5235A (is) 1999-10-29
EP0984960A1 (de) 2000-03-15
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
NO995513L (no) 2000-01-12
NZ500637A (en) 2000-11-24
DE69811223T2 (de) 2003-11-27
BR9811465A (pt) 2000-09-12
HUP0002763A3 (en) 2002-05-28
HRP980258B1 (en) 2002-08-31
RU2175323C2 (ru) 2001-10-27
PL336772A1 (en) 2000-07-17
KR20010012541A (ko) 2001-02-15
AU725530B2 (en) 2000-10-12
GT199800068A (es) 1999-11-11
EE9900524A (et) 2000-06-15
ZA983997B (en) 1999-11-12
HRP980258A2 (en) 1999-02-28
CO4940485A1 (es) 2000-07-24
JP2001524980A (ja) 2001-12-04
ATE232207T1 (de) 2003-02-15
WO1998051686A1 (fr) 1998-11-19
SK154299A3 (en) 2000-05-16
CZ289484B6 (cs) 2002-01-16
CZ400699A3 (cs) 2000-02-16
DE69811223D1 (de) 2003-03-13
ES2190081T3 (es) 2003-07-16
TR199902795T2 (xx) 2000-02-21
HUP0002763A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO972983D0 (no) Sulfonamider og deres anvendelse
NO991922D0 (no) Heteroarylsuccinamider og deres anvendelse som metalloproteinaseinhibitorer
NO20022334L (no) Ny sammensetning og anvendelse
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
NO993522L (no) 4-(3-heterocyclyl-1-benzoyl)pyrazoler og anvendelse derav som herbicider
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO992492D0 (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DK1015434T3 (da) Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
DK1012137T3 (da) Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
NO973338D0 (no) N-(4-aryl-tiazol-2-yl)-sulfonamid-derivater og deres anvendelse
DK0984960T3 (da) N-triazol-2-indolcarboxamider og deres anvendelse som CCK-A-agonister
DK0989121T3 (da) Substituerede benzamider og deres anvendelse som immunmodulatorer
DK1112003T3 (da) Ny sammensætning og anvendelse
NO962952L (no) 1,2,4-oksadiazolderivater og deres anvendelse som parasitticider for dyr
NO994510D0 (no) Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DK1021156T3 (da) Kosmetiske vaskesammensætninger og deres anvendelse
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
NO20003142L (no) Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO984921D0 (no) Tienopyridinderivater og deres anvendelse